open access

Vol 6, No 1 (2021)
Original article
Published online: 2021-02-08
Get Citation

Effect of Lactobacillus spp. strains on the population of Listeria monocytogenes isolated from the human vagina

Krzysztof Skowron1, Ewa Wałecka-Zacharska2, Natalia Wiktorczyk-Kapischke1, Katarzyna Grudlewska-Buda1, Zuzanna Bernaciak1, Anna Gralewska1, Eugenia Gospodarek-Komkowska1
·
Medical Research Journal 2021;6(1):8-15.
Affiliations
  1. Nicolaus Copernicus University in Toruń, Collegium Medicum of L. Rydygier in Bydgoszcz, M. Skłodowskiej-Curie 9, 85-094 Bydgoszcz, Poland
  2. Department of Food Hygiene and Consumer Health, Wrocław University of Environmental and Life Sciences, 31 C.K. Norwida St., 50-375 Wrocław, Poland

open access

Vol 6, No 1 (2021)
ORIGINAL ARTICLES
Published online: 2021-02-08

Abstract

Introduction: The normal vaginal microbiota (mainly Lactobacillus spp.) affects the health of these areas. Bacterial vaginosis is a serious health problem among many women, especially dangerous for pregnant women. The study aimed to assess the impact of Lactobacillus spp. strains on the population of Listeria monocytogenes isolated from women.

Materials and methods: The research material consisted of reference strains of Lactobacillus spp.: L. acidophilus (LAC), L. fermentum (LFE), L. gasseri (LGA), L. plantarum (LPL), the strain L. monocytogenes ATCC 19111 and 7 L. monocytogenes strains isolated from the vagina.

Results: The highest antagonistic activity was shown for the mixed culture of all Lactobacillus strains (LACTO MIX) used in the experiment. Among the individual strains of Lactobacillus spp. strains, L. plantarum turned out to most effectively reduce L. monocytogenes number (reduction of 5.74 log CFU × ml-1). The least effective in inhibiting the growth of L. monocytogenes was the L. acidophilus strain (reduction of L. monocytogenes of a number of 2.21 log CFU × ml-1).

Conclusions: The presence of Lactobacillus spp. in the genital tract limits the development of bacterial infections, which is an important aspect especially for pregnant women.

Abstract

Introduction: The normal vaginal microbiota (mainly Lactobacillus spp.) affects the health of these areas. Bacterial vaginosis is a serious health problem among many women, especially dangerous for pregnant women. The study aimed to assess the impact of Lactobacillus spp. strains on the population of Listeria monocytogenes isolated from women.

Materials and methods: The research material consisted of reference strains of Lactobacillus spp.: L. acidophilus (LAC), L. fermentum (LFE), L. gasseri (LGA), L. plantarum (LPL), the strain L. monocytogenes ATCC 19111 and 7 L. monocytogenes strains isolated from the vagina.

Results: The highest antagonistic activity was shown for the mixed culture of all Lactobacillus strains (LACTO MIX) used in the experiment. Among the individual strains of Lactobacillus spp. strains, L. plantarum turned out to most effectively reduce L. monocytogenes number (reduction of 5.74 log CFU × ml-1). The least effective in inhibiting the growth of L. monocytogenes was the L. acidophilus strain (reduction of L. monocytogenes of a number of 2.21 log CFU × ml-1).

Conclusions: The presence of Lactobacillus spp. in the genital tract limits the development of bacterial infections, which is an important aspect especially for pregnant women.

Get Citation

Keywords

Lactobacillus spp., Listeria monocytogenes, vaginal disease, probiotics, antagonistic action

About this article
Title

Effect of Lactobacillus spp. strains on the population of Listeria monocytogenes isolated from the human vagina

Journal

Medical Research Journal

Issue

Vol 6, No 1 (2021)

Article type

Original article

Pages

8-15

Published online

2021-02-08

Page views

655

Article views/downloads

638

DOI

10.5603/MRJ.a2021.0001

Bibliographic record

Medical Research Journal 2021;6(1):8-15.

Keywords

Lactobacillus spp.
Listeria monocytogenes
vaginal disease
probiotics
antagonistic action

Authors

Krzysztof Skowron
Ewa Wałecka-Zacharska
Natalia Wiktorczyk-Kapischke
Katarzyna Grudlewska-Buda
Zuzanna Bernaciak
Anna Gralewska
Eugenia Gospodarek-Komkowska

References (20)
  1. Borges S, Silva J, Teixeira P. The role of lactobacilli and probiotics in maintaining vaginal health. Arch Gynecol Obstet. 2014; 289(3): 479–489.
  2. Eslami G, Karimiravesh R, Taheri S, et al. Inhibitory Effect of Lactobacillus reuteri on Some Pathogenic Bacteria Isolated From Women With Bacterial Vaginosis. Avicenna Journal of Clinical Microbiology and Infection. 2014; 1(2): 19908–19908.
  3. Strus M. Podstawy stosowania probiotyków dopochwowych w zakażeniach narządu moczowo-płciowego. Zakażenia. 2005; 4: 40–43.
  4. Strus M, Malinowska M. Zakres antagonistycznego działania bakterii z rodzaju Lactobacillus na czynniki etiologiczne waginozy bakteryjnej. Med Dośw Mikrobiol. 1999; 51: 47–57.
  5. Farage M, Miller K, Sobel J. Dynamics of the Vaginal Ecosystem—Hormonal Influences. Infectious Diseases: Research and Treatment. 2010; 3: IDRT.S3903.
  6. Cribby S, Taylor M, Reid G. Vaginal microbiota and the use of probiotics. Interdiscip Perspect Infect Dis. 2008; 2008: 256490.
  7. Amabebe E, Anumba DOC. The Vaginal Microenvironment: The Physiologic Role of . Front Med (Lausanne). 2018; 5: 181.
  8. Jurkiewicz A, Oleszczak-Momot W. Listeria monocytogenes jako problem zdrowia publicznego. Medycyna Ogólna i Nauki o Zdrowiu. 2015; 21(1): 29–32.
  9. Madjunkov M, Chaudhry S, Ito S. Listeriosis during pregnancy. Arch Gynecol Obstet. 2017; 296(2): 143–152.
  10. Jin L, Tao L, Pavlova SI, et al. Species diversity and relative abundance of vaginal lactic acid bacteria from women in Uganda and Korea. J Appl Microbiol. 2007; 102(4): 1107–1115.
  11. Atassi F, Brassart D, Grob P, et al. Lactobacillus strains isolated from the vaginal microbiota of healthy women inhibit Prevotella bivia and Gardnerella vaginalis in coculture and cell culture. FEMS Immunol Med Microbiol. 2006; 48(3): 424–432.
  12. Gil NF, Martinez RCR, Gomes BC, et al. Vaginal lactobacilli as potential probiotics against Candida SPP. Braz J Microbiol. 2010; 41(1): 6–14.
  13. Bodaszewska-Lubas M, Brzychczy-Wloch M, Gosiewski T, et al. Antibacterial activity of selected standard strains of lactic acid bacteria producing bacteriocins--pilot study. Postepy Hig Med Dosw (Online). 2012; 66: 787–794.
  14. Stoyancheva G, Marzotto M, Dellaglio F, et al. Bacteriocin production and gene sequencing analysis from vaginal Lactobacillus strains. Arch Microbiol. 2014; 196(9): 645–653.
  15. Matu MN, Orinda GO, Njagi ENM, et al. In vitro inhibitory activity of human vaginal lactobacilli against pathogenic bacteria associated with bacterial vaginosis in Kenyan women. Anaerobe. 2010; 16(3): 210–215.
  16. Sabia C, Anacarso I, Bergonzini A, et al. Detection and partial characterization of a bacteriocin-like substance produced by Lactobacillus fermentum CS57 isolated from human vaginal secretions. Anaerobe. 2014; 26: 41–45.
  17. Dembélé T, Obdrzálek V, Votava M. Inhibition of bacterial pathogens by lactobacilli. Zentralbl Bakteriol. 1998; 288(3): 395–401.
  18. Hütt P, Lapp E, Štšepetova J, et al. Characterisation of probiotic properties in human vaginal lactobacilli strains. Microb Ecol Health Dis. 2016; 27: 30484.
  19. Kjos M, Nes IF, Diep DB. Mechanisms of resistance to bacteriocins targeting the mannose phosphotransferase system. Appl Environ Microbiol. 2011; 77(10): 3335–3342.
  20. Kaur G, Malik RK, Mishra SK, et al. Nisin and class IIa bacteriocin resistance among Listeria and other foodborne pathogens and spoilage bacteria. Microb Drug Resist. 2011; 17(2): 197–205.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl